KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $16,000 | +128.6% | 150 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $7,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $7,000 | -12.5% | 150 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $8,000 | +60.0% | 150 | +50.0% | 0.00% | +50.0% |
| Q2 2016 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -16.7% | 100 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $6,000 | 0.0% | 100 | 0.0% | 0.01% | +100.0% |
| Q3 2015 | $6,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|